Tag: psychedelic therapy leadership

  • The Broken Promises by Psychedelic Therapy Leadership

    A Critical Look at MDMA, Ketamine, and Ibogaine — and the Industry’s Greed In the early 2000s, a promise echoed through the burgeoning psychedelic community: MDMA, the euphoria-inducing compound known colloquially as ecstasy, would revolutionize mental health treatment. Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), stood at the forefront of this…